Oracle Prices $14 Billion Aggregate Principal Amount of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Oracle Prices $14 Billion Aggregate Principal Amount of Investment Grade Notes

REDWOOD SHORES, CA--(Marketwired - Jun 29, 2016) - Oracle Corporation ( NYSE : ORCL ) announced the pricing of its sale of $4,250,000,000 of 1.900% Notes due 2021 (the "2021 Notes"), $2,500,000,000 of 2.400% Notes due 2023 (the "2023 Notes"), $3,000,000,000 of 2.650% Notes due 2026 (the "2026 Notes"), $1,250,000,000 of 3.850% Notes due 2036 (the "2036 Notes") and $3,000,000,000 of 4.000% Notes due 2046 (the "2046 Notes"). The offering is expected to settle on July 7, 2016, subject to customary closing conditions.

The 2021 Notes will bear interest at the rate of 1.900% per year, the 2023 Notes will bear interest at the rate of 2.400% per year, the 2026 Notes will bear interest at the rate of 2.650% per year, the 2036 Notes will bear interest at the rate of 3.850% per year and the 2046 Notes will bear interest at the rate of 4.000% per year. Interest will be payable semi-annually on March 15 and September 15 for each of the 2021 Notes and the 2023 Notes, commencing March 15, 2017, and payable semi-annually on January 15 and July 15 for the 2026 Notes, the 2036 Notes and the 2046 Notes, commencing January 15, 2017.

Oracle intends to use the net proceeds of the offering for general corporate purposes, which may include stock repurchases, payment of cash dividends on its common stock, repayment of indebtedness and future acquisitions.

The offering is being made through an underwriting syndicate led by Citigroup Global Markets Inc., HSBC Securities (USA) Inc., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Wells Fargo Securities, LLC.

The offering of these securities is made only by means of a prospectus, copies of which may be obtained by contacting: Citigroup Global Markets, Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or telephone: 1-800-831-9146 ; HSBC Securities (USA) Inc. by mail at 452 5th Avenue, New York, NY, 10018, Attention: Transaction Management Americas, by telephone at 1-866-811-8049 or by email at tmg.americas@us.hsbc.com ; J.P. Morgan Securities LLC, Attention: Investment Grade Syndicate Desk, 383 Madison Ave., New York, NY 10179, Telephone: (212) 834-4533 ; Merrill Lynch, Pierce, Fenner & Smith Incorporated, NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte NC 28255-0001, Attn: Prospectus Department, Email: dg.prospectus_requests@baml.com or Wells Fargo Securities, LLC, Attention: WFS Customer Service, 608 2nd Avenue, South Minneapolis, MN 55402, Telephone: (800) 645-3751 .

The notes are being offered pursuant to an automatically effective shelf registration statement filed with the U.S. Securities and Exchange Commission on March 18, 2016.

Important Information

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful.

About Oracle

Oracle offers a comprehensive and fully integrated stack of cloud applications and platform services.

Trademarks

Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

Contact Info Ken Bond Oracle Investor Relations +1.650.607.0349 Email Contact Deborah Hellinger Oracle Corporate Communications +1.212.508.7935 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 124

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 7

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 415

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 324

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 136

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 77

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 42

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 44

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 258

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

VOOG's 15-Year Climb: Compounding Gains or Just a Mirage?

Updated Category News Views 255

Fifteen years back, you could have dropped $1000 into the Vanguard S&P 500 Growth ETF (NYSE:VOOG), and that cash would’ve exploded into a whopping $7,164.65 today. That’s a staggering annualized return of 14.01%, comfortably outpacing the market by about 2.35%. Sounds easy, right? But let’s peel back this seemingly golden curtain. VOOG's Performance: The Big Picture...

Continue Reading
Mercer International Inc. Faces Financial Challenges in Q2 2025

Updated Category News Views 256

Financial Overview of Mercer International Inc. for Q2 2025 Mercer International Inc. recently disclosed its financial performance for the second quarter of 2025, revealing significant challenges. The company reported an Operating EBITDA of negative $20.9 million alongside a net loss of $86.1 million, a stark contrast to the positive $30.4 million Operating EBITDA and a...

Continue Reading
EU's Strategic Response to Potential Trade Challenges with Trump

Updated Category News Views 167

EU's Trade Engagement Strategy with the New Administration The European Union is gearing up for an essential phase in its trade relations with the U.S. as Donald Trump prepares to take office once again. The EU's ministers have clearly expressed the need to foster constructive dialogue regarding trade policies while remaining vigilant about any potential tariff...

Continue Reading
Regenative Labs Casts Spotlight on Plantar Fascia Innovations

Updated Category News Views 44

Rethinking Plantar Fasciitis with Wharton’s Jelly When it comes to those of us keeping an eye on regenerative medicine, it’s like standing on the edge of a wild frontier sometimes. Today, we’ve got Regenative Labs out of Pensacola shining a light on something that’s often a real pain—literally and figuratively: plantar fasciitis. Clinical Studies with Promising...

Continue Reading
GC Biopharma's BARYCELA Secures Marketing Authorization

Updated Category News Views 171

GC Biopharma's Breakthrough with BARYCELA GC Biopharma, a prominent South Korean pharmaceutical company, has achieved a significant milestone with the recent marketing authorization of its varicella vaccine, BARYCELA, in Vietnam. This accomplishment follows earlier domestic approval and WHO Pre-Qualification, demonstrating the company’s commitment to expanding its...

Continue Reading